News
FDA Grants Pharmacies Extra Year For Security Compliance
The implementation of the Drug Supply Chain Security Act has been postponed until November 2024, granting pharmacies an additional year to prepare for compliance with the law's drug distribution security requirements. Originally passed in 2013, the full enforcement was...
Drug Research
Recipharm partners with Ahead Therapeutics to develop rare autoimmune disease therapy
Global contract development and manufacturing organisation (CDMO) Recipharm is partnering with Ahead Therapeutics to develop a ground-breaking treatment for a rare autoimmune disease, myasthenia gravis. Ahead Therapeutics is a Spanish start-up biotech company, using proprietary technology to develop treatments for different autoimmune disorders.
Under...
News
Early Phase Clinical Trials in Immunology
Immunology, the intricate study of our body's defense mechanism, has been at the epicenter of several groundbreaking medical research studies. As we delve deeper into understanding our immune system, new potential treatments and drugs emerge. But before they can...
News
Peli BioThermal Exhibit Life-Saving Range at DSEI
Peli BioThermal, the life science industry’s partner from discovery to distribution, will be exhibiting its award-winning products at DSEI 2023.
The company’s team of experts will be sharing knowledge and showcasing its life-saving products at the world’s largest gathering of...
News
Booming Asia Pacific Pharmaceutical Glass Packaging Market
The Pharmaceutical Glass Packaging Market has been anticipated to have a valuation of approximately USD 28.27 billion in the year 2023, with an anticipated increase to USD 36.58 billion by the year 2028, reflecting a growth rate of 5.29%...
News
North America Leads The Way In CGT Quality Control Market
As per a report from Transparency Market Research Inc., the global market for quality control in the manufacturing of CGT (cell and gene therapies) is anticipated to reach a value of $2.8 billion by the year 2031. It is...
Drug Research
Waste Management Strategies For Antibiotic Manufacturers
In 2023, the pharmaceutical industry, particularly antibiotic manufacturers, has experienced a range of changes that span from supply chain challenges to new regulatory opportunities. A recent insight from the Access to Medicine Foundation has brought attention to the issue...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















